Senior insider sale
See Remarks at BRIDGEBIO PHARMA, INC. — senior position signals high conviction
$10.02M
141.08K shares
What this filing means
KUMAR NEIL plans to sell 141.08K shares of BRIDGEBIO PHARMA, INC. valued at approximately $10.02M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/18/2026ACC: 0001950047-26-008337
DirectorOfficer· See Remarks
Since Jun 2019
141.08K
Shares to sell
$10.02M
Approx. market value
34.98K
Acquired (3 months)
1
Planned
5 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
8/16/2026
34.98KTotal acquired34.98K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/16/2026 | Restricted Stock Units N/A | 34.98K | — |
| Total | 34.98K | ||
Planned & Completed Dispositions6
Completed
—Completed
Units to sell
20K
Market value
$1.36M
6/5/2026
—Completed
Units to sell
20K
Market value
$1.36M
6/5/2026
—Completed
Units to sell
20K
Market value
$1.35M
6/4/2026
—Completed
Units to sell
20K
Market value
$1.35M
6/4/2026
—Completed
Units to sell
26.10K
Market value
$1.81M
5/21/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
34.98K
Market value
$2.79M
8/18/2026
Total
Units
141.08K
Value
$10.02M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/5/2026 | 20K | $1.36M | — | Completed |
6/5/2026 | 20K | $1.36M | — | Completed |
6/4/2026 | 20K | $1.35M | — | Completed |
6/4/2026 | 20K | $1.35M | — | Completed |
5/21/2026 | 26.10K | $1.81M | — | Completed |
| Planned — Approximate Date | ||||
8/18/2026 | 34.98K | $2.79M | NASDAQ | Planned |
| Total | 141.08K | $10.02M | ||